[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100505403":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":31,"locations":41,"responsibleParty":204,"collaborators":207,"id":213,"slug":214,"hasResults":215,"nctId":216,"briefTitle":217,"officialTitle":218,"acronym":18,"eligibilityCriteria":219,"healthyVolunteers":215,"sex":220,"minAge":221,"maxAge":222,"enrollmentInfo":223,"targetDuration":18,"studyType":226,"phases":227,"briefSummary":229,"conditions":230,"keywords":232,"overallStatus":237,"whyStopped":18,"lastUpdateSubmitDate":238,"lastUpdatePostDateStruct":239,"startDateStruct":242,"completionDateStruct":244,"leadSponsor":246,"locationsCount":247},{"fullName":5,"class":6},"Fudan University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Huaier Granule+Standard treatment","EXPERIMENTAL","The subject is administered according to the clinical dosage and method of medication until disease progression occurs or the subject is unable to tolerate treatment.Subjects receiving routine diagnosis and treatment simultaneously.",[13],"Drug: Huaier Granule",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard treatment","NO_INTERVENTION","Subjects receive routine diagnosis and treatment without taking Huaier granules.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Huaier Granule","10g each time, three times a day",[9],[26],"Z20000109（NMPA Approval Number）",[28],{"name":29,"affiliation":5,"role":30},"Zhimin Shao, Professor","PRINCIPAL_INVESTIGATOR",[32,37],{"name":33,"role":34,"phone":35,"phoneExt":18,"email":36},"Zhimin Shao, PhD","CONTACT","+8618017312288","zhimingshao@yahoo.com",{"name":38,"role":34,"phone":39,"phoneExt":18,"email":40},"Liang Huang, PhD","+8618121299334","fdhlyx@163.com",[42,59,73,87,97,111,124,138,147,156,170,178,191],{"facility":43,"status":18,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"The Fourth Hospital of Hebei Medical University","Shijiazhuang","Hebei","050011","China","CN",{"type":50,"coordinates":51},"Point",[52,53],114.47861,38.04139,{"lat":53,"lon":52},[56],{"name":57,"role":34,"phone":58,"phoneExt":18,"email":18},"Li Ma, PhD","+8613932116886",{"facility":60,"status":18,"city":61,"state":62,"zip":63,"country":47,"countryCode":48,"cosmosGeoPoint":64,"geoPoint":68,"contacts":69},"The First Affiliated Hospital of Zhengzhou University","Zhengzhou","Henan","450052",{"type":50,"coordinates":65},[66,67],113.64861,34.75778,{"lat":67,"lon":66},[70],{"name":71,"role":34,"phone":72,"phoneExt":18,"email":18},"Xin Ge, PhD","+8613303719081",{"facility":74,"status":18,"city":75,"state":76,"zip":77,"country":47,"countryCode":48,"cosmosGeoPoint":78,"geoPoint":82,"contacts":83},"The First Hospital of Hunan University of Chinese Medicine","Changsha","Hunan","410011",{"type":50,"coordinates":79},[80,81],112.97087,28.19874,{"lat":81,"lon":80},[84],{"name":85,"role":34,"phone":86,"phoneExt":18,"email":18},"Jinhui Hu, PhD","+8613637412178",{"facility":88,"status":18,"city":75,"state":76,"zip":89,"country":47,"countryCode":48,"cosmosGeoPoint":90,"geoPoint":92,"contacts":93},"The Third Xiangya Hospital of Central South University","410013",{"type":50,"coordinates":91},[80,81],{"lat":81,"lon":80},[94],{"name":95,"role":34,"phone":96,"phoneExt":18,"email":18},"Boni Ding, PhD","+8613627418663",{"facility":98,"status":18,"city":99,"state":100,"zip":101,"country":47,"countryCode":48,"cosmosGeoPoint":102,"geoPoint":106,"contacts":107},"Nantong First People's Hospital","Nantong","Jiangsu","226006",{"type":50,"coordinates":103},[104,105],120.87472,32.03028,{"lat":105,"lon":104},[108],{"name":109,"role":34,"phone":110,"phoneExt":18,"email":18},"Jinpeng Chen, PhD","+8618551315594",{"facility":112,"status":18,"city":113,"state":100,"zip":114,"country":47,"countryCode":48,"cosmosGeoPoint":115,"geoPoint":119,"contacts":120},"Northern Jiangsu People's Hospital","Yangzhou","225001",{"type":50,"coordinates":116},[117,118],119.43583,32.39722,{"lat":118,"lon":117},[121],{"name":122,"role":34,"phone":123,"phoneExt":18,"email":18},"Deyuan Fu, PhD","+8618051060677",{"facility":125,"status":18,"city":126,"state":127,"zip":128,"country":47,"countryCode":48,"cosmosGeoPoint":129,"geoPoint":133,"contacts":134},"The International Peace Maternity & Child Health Hospital of China welfare institute","Shanghai","Shanghai Municipality","200030",{"type":50,"coordinates":130},[131,132],121.45806,31.22222,{"lat":132,"lon":131},[135],{"name":136,"role":34,"phone":137,"phoneExt":18,"email":18},"Jie Wang, PhD","+8618017316231",{"facility":139,"status":18,"city":126,"state":127,"zip":140,"country":47,"countryCode":48,"cosmosGeoPoint":141,"geoPoint":143,"contacts":144},"Fudan University Shanghai Cancer Center","200032",{"type":50,"coordinates":142},[131,132],{"lat":132,"lon":131},[145,146],{"name":33,"role":34,"phone":35,"phoneExt":18,"email":36},{"name":38,"role":34,"phone":39,"phoneExt":18,"email":40},{"facility":148,"status":18,"city":126,"state":127,"zip":149,"country":47,"countryCode":48,"cosmosGeoPoint":150,"geoPoint":152,"contacts":153},"Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","200092",{"type":50,"coordinates":151},[131,132],{"lat":132,"lon":131},[154],{"name":155,"role":34,"phone":35,"phoneExt":18,"email":18},"Baosan Han, PhD",{"facility":157,"status":18,"city":158,"state":159,"zip":160,"country":47,"countryCode":48,"cosmosGeoPoint":161,"geoPoint":165,"contacts":166},"Zhejiang Cancer Hospital","Hangzhou","Zhejiang","310005",{"type":50,"coordinates":162},[163,164],120.16142,30.29365,{"lat":164,"lon":163},[167],{"name":168,"role":34,"phone":169,"phoneExt":18,"email":18},"Xiaojia Wang, PhD","+8613906500190",{"facility":171,"status":18,"city":172,"state":159,"zip":173,"country":47,"countryCode":48,"cosmosGeoPoint":18,"geoPoint":18,"contacts":174},"The First Hospital of Jiaxin","Jiaxin","314000",[175],{"name":176,"role":34,"phone":177,"phoneExt":18,"email":18},"Caiping Chen, PhD","+8613967370819",{"facility":179,"status":18,"city":180,"state":159,"zip":181,"country":47,"countryCode":48,"cosmosGeoPoint":182,"geoPoint":186,"contacts":187},"Lishui Municipal Central Hospital","Lishui","323020",{"type":50,"coordinates":183},[184,185],119.91029,28.46042,{"lat":185,"lon":184},[188],{"name":189,"role":34,"phone":190,"phoneExt":18,"email":18},"Shuzheng Chen, PhD","+8613567618556",{"facility":192,"status":18,"city":193,"state":159,"zip":194,"country":47,"countryCode":48,"cosmosGeoPoint":195,"geoPoint":199,"contacts":200},"Taizhou Central Hospital","Taizhou","318001",{"type":50,"coordinates":196},[197,198],121.43312,28.66266,{"lat":198,"lon":197},[201],{"name":202,"role":34,"phone":203,"phoneExt":18,"email":18},"Yuechu Dai, PhD","+8613906768336",{"type":30,"investigatorFullName":205,"investigatorTitle":206,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Zhimin Shao","professor",[208,211],{"name":209,"class":210},"LinkDoc Technology (Beijing) Co. Ltd.","INDUSTRY",{"name":212,"class":6},"Huazhong University of Science and Technology","100505403","phase-4-clinical-study-of-huaier-granules-in-patients-with-advanced-breast-cancer-without-visceral-metastasis-100505403",false,"NCT05860907","Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis","A Multicenter, Open-label, Randomized, Controlled, Prospective Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis","Inclusion Criteria:\n\n* 18 years old ≤ age ≤ 75, regardless of gender.\n* For breast cancer patients who are clinically or pathologically diagnosed as non visceral metastasis, if the patient has only local recurrence or metastasis, the clinician judges that it is not suitable or refuses to use local treatment with radical intensity, such as surgical resection or radiotherapy.\n* Prior to enrollment, no more than first-line chemotherapy\u002Fendocrine therapy\u002Ftargeted therapy\u002Fimmunotherapy were allowed;If the patient has previously received first-line therapy, the outcome of treatment should be clinically assessed as disease progression or intolerance.\n* There is at least one measurable lesion that meets the RECIST 1.1 standard, or only bone metastases (including osteolytic lesions or mixed lesions).\n* The liver and kidney functions meet the following conditions: AST and ALT\\\u003C3 ULN, total bilirubin ≤ 2 ULN, and blood creatinine\\\u003C1.5 ULN.\n* Other laboratory tests meet the following requirements: Hb ≥ 9g\u002Fdl, platelet count ≥ 60 × 10\\^9\u002FL, absolute neutrophil count\\>1.0 × 10\\^9\u002FL.\n* Expected survival time ≥ 12 weeks.\n* The patient's ECOG physical state score is 0 or 1.\n* The subjects participated in the study voluntarily and signed an informed consent form.\n\nExclusion Criteria:\n\n* Any other malignancies diagnosed within 5 years prior to enrollment, except those with a low risk of metastasis and death (5-year survival \\> 90%), such as adequately treated basal cell or squamous cell skin cancer or cervical carcinoma in situ.\n* There is visceral metastasis of breast cancer.\n* Patients with advanced (local recurrence or metastasis) breast cancer who plan to receive radical local treatment.\n* Serious infections (CTCAE\\>Level 2) have occurred within 4 weeks prior to enrollment, such as severe pneumonia, bacteremia, infection complications that require hospitalization; Symptoms and signs of infection or the need for oral or intravenous antibiotic treatment within 2 weeks prior to enrollment, except for prophylactic use of antibiotics.\n* Suffering from severe acute and chronic diseases.\n* Suffering from severe diabetes whose blood sugar cannot be effectively controlled.\n* Patients who cannot take oral medication or are allergic to the ingredients of Huaier granules.\n* Drug abusers, or those who suffer from psychological or mental illnesses that may interfere with research compliance.\n* Pregnant or lactating women.\n* The researcher believes that it is not suitable to participate in this study.","ALL","18 Years","75 Years",{"count":224,"type":225},384,"ESTIMATED","INTERVENTIONAL",[228],"PHASE4","This is a multicenter, open-label, randomized controlled, prospective clinical study to evaluate the efficacy and safety of Huaier Granules in patients with advanced breast cancer without visceral metastasis.",[231],"Breast Cancer Stage IV",[233,234,235,236],"non-visceral metastasis","Huaier granule","randomized controlled","prospective clinical study","NOT_YET_RECRUITING","2023-09-22",{"date":240,"type":241},"2023-09-26","ACTUAL",{"date":243,"type":225},"2023-10",{"date":245,"type":225},"2027-10",{"name":5,"class":6},13]